CLINICAL_TRIALS
trial_result
· 2019-04-19
Clinical Trial Update: Pharmacokinetic Study of Subcutaneous Testosterone Enanthate [Phase 1]
Summary
Phase 1 pharmacokinetic study of subcutaneous testosterone enanthate in hypogonadism completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Antares Pharma Inc. | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED | Results posted: 2019-04-19